EFFICACY OF ZINC AS AN ANTIBACTERIAL AGENT AGAINST ENTERIC BACTERIAL PATHOGENS

Umaira Faiz, Tariq Butt, Luqman Satti, Wajid Hussain, Faisal Hanif

Abstract


Background: Diarrhoea is a serious threat all over the world with great economic implications
especially evident in the developing world. This study was aimed at determining in vitro efficacy
of Zinc (Zn) against common enteric bacterial pathogens. Method: A total of 100 bacterial enteric
pathogens: Salmonellae (n=16), enteropathogenic Escherichia coli (EPEC) (n=26), Shigellae
(n=28) and Vibrio cholerae (n=30) were isolated from diarrhoeal stool specimens at Department
of Microbiology, Armed Forces Institute of Pathology Rawalpindi during Aapril 2009 to Jan 2010.
These isolates were tested against various concentrations of Zn supplemented in Mueller Hinton
(MH) agar using a multipoint inoculator. A minimum inhibitory concentration of active Zn in
ZnSO4.7H2O ranging from 0.03 mg/ml to 1 mg/ml was used. Results: Zn completely inhibited
the growth of all the tested pathogens and most of them were inhibited at a concentration of 0.06
mg/ml to 0.5 mg/ml of Zn. Conclusions: Zinc has an excellent antibacterial activity against
enteric bacterial pathogens common in our setup which may provide basis for treatment of
diarrhoea. Clinical study based on these findings is recommended.
Keywords: Diarrhoea, zinc, antibacterial, Enteric Pathogens, Cholera, Salmonella, E. coli, Shigella

Full Text:

PDF

References


Black RE, Morris SS, Bryce J. Where and why are 10 million

children dying every year? Lancet 2003;361:2226–34.

Sur D, Ramamurthy T, Deen J, Bhattacharya SK. Shigellosis:

challenges & management issues. Indian J Med Res

;120:454–62.

Jafari F, Shokrzadeh L, Hamidian M, Ahrabi SS, Zali MR. Acute

Diarrhoea due to Enteropathogenic Bacteria in Patients at

Hospital in Tehran. Jpn J Infect Dis 2008;61:269–73.

Hoque KM, Binder HI. Zinc in the treatment of acute diarrhea:

Current status and assessment. Gastroenterology 2006;130:2201–5.

Strand TA, Chandyo RK, Bahl R, Sharma PR, Adhikari RK,

Bhandari N, et al. Effectiveness and Efficacy of Zinc for the

Treatment of Acute Diarrhoea in Young Children. Pediatrics

;109:898–903.

Faruque AS, Mahalanabis D, Haque SS, Fuchs GJ, Habte D.

Double-blind, randomized, controlled trial of zinc or vitamin A

supplementation in young children with acute diarrhea. Acta

Paediatr 1999;88:154–60.

Bhutta ZA, Bird SM, Black RE, Brown KH, Gardner JM,

Hadayat A, et al. Zinc Investigators’ Collaborative Group.

Therapeutic effects of oral zinc in acute and persistent diarrhoea

in children in developing countries: pooled analysis of

randomised controlled trials. Am J Clin Nutr 2000;72:1516–22.

Baqui AH, Black RE, Arifeen EI, Yunus M, Chakra-borty J,

Ahmad S, et al. Effect of zinc supplementation started during

diarrhea on morbidity and mortality in Bangladeshi children:

community randomized trial. BMJ 2002;325:1059.

Schreckenberger PC, Linquist D. Algorithms for identification of

Aerobic Gram-Negative bacteria. In: Murray PR, Baron EJ,

Jorgensen JH, Landry ML, Pfaller MA, (eds.). Manual of

Clinical Microbiology, 9th ed, Washington DC: ASM Press,

: p.371.

WHO mortality country fact sheet 2006. Available from:

http://www.who.int/whosis/mort/profiles/mort_emro_pak_pakist

an.pdf

WHO/UNICEF Joint Statement. Clinical management of acute

diarrhea. Geneva: World Health Organization, 2004. p.7.

Scrimgeour AG, Lukaski HC. Zinc and diarrheal disease: current

status and future perspectives. Curr Opin Clin Nutr Metab Care

;11:711–7.

Larson CP, Hoque AM, Larson CP, Khan AM, Saha UR.

Initiation of zinc treatment for acute childhood diarrhea and risk

for vomiting or regurgitation: A randomized, double-blind,

placebo-controlled trial. J Health Popul Nutr 2005;23:311–9.

Crane JK, Hoque KM. Zinc for Infectious Diarrhea in Developed

Countries: Should We Be Sprinkling Our Own Lawns? Journal

of Pediatric Gastroenterol Nut 2008;46:484–5.

Sawai J. Quantitative evaluation of antibacterial activities of

metallic oxide powders (ZnO, MgO and CaO) by conductimetric

assay. J Microbiol Methods 2003;54:177–82.

Selahattin A, Kadri G, Ramazan C. Effect of zinc on microbial

growth. Tr J Med Sciences 1998;28:595–7.

Canani R, Ruotolo S. The Dawning of the “Zinc Era” in the

Treatment of Pediatric Acute Gastroenteritis Worldwide? J

Pediatr Gastroenterol Nutr 2006;42:253–5.

Chart H. Escherichia. In: Greenwood D, Slack RC, Peutherer JF,

(eds.). Medical Microbiology A guide to Microbial Infections:

Pathogenesis, Immunity, Laboratory diagnosis and Control, 16th

ed, Philadelphia: Elsevier Inc; 2006. p.265–74.

Ranjbar R, Dallal MM, Pourshaffie MR. Epidemiology of

shigellosis with special reference to hospital distribution of

Shigella strains in Tehran. Iranian J Clin Infect Dis 2008;3:35–8.

Samal SK, Khunita HK, Nanda PK, Satapathay CS, Nayak SR,

Sarangi AK, et al. Incidence of Bacterial Enteropathogens among

Hospitalized Diarrhoea Patients from Orisa, India. Jpn J Infect

Dis 2008;61;350–5.

Seidlein LV, Kim DR, Ali M, Lee H, Wang XY, Thiem VD, et

al. A Multicentre Study of Shigella Diarrhoea in six Asian

Countries: Disease Burden, Clinical Manifestations and

Microbiology. PLoS Med. 2006;3:e353.

Surjawidaja JE, Hidayat A, Lesmana M. Growth inhibition of

enteric pathogens by Zinc Sulphate: an in vitro study. Med Princ

Prac 2004;13:286–9.

Iwalokun BA, Bakare S. Comparative sensitivity to Zinc

Sulphate of Shigella isolates recovered from Nigerian children

with low and marginal plasma zinc concentrations. J Pediatr

Infect Dis 2008;3:167–74.

Crane JK, Naeher TM, Shulgina I, Zhu C, Boedeker EC. Effect

of zinc in Enteropathogenic Escherichia coli infection. Infect

Immun 2007;75:5974–84.


Refbacks

  • There are currently no refbacks.


Contact Number: +92-992-382571

email: [jamc] [@] [ayubmed.edu.pk]